Post by Serhii Vakal
PhD | Computational Drug Discovery Architect | Designing End-to-End Modeling Pipelines | Computational Chemistry | Lead ML/AI Scientist | Generative AI for Molecular Design
During my two years in China's life sciences sector from 2017 to 2019, I saw firsthand how computational tools were starting to reshape drug discovery. Now, with AI advancing at a steady clip, I'm sometimes asked: What's really happening in this space today? In this article, I break down the key developments, from techbio hubs in Shanghai and Shenzhen to multi-billion-dollar global deals, offering a clear view of a sector that's quietly gaining ground worldwide. Read on for the details, including the challenges ahead. #ChineseBiotech #ChinaInnovation #CADD #AIDD #ComputationalChemistry #DrugDiscovery #DrugDesign #Techbio #Pharma #Biopharma #AIinHealthcare
